Company: CLX
Filing Date: 2025-10-07
Form Type: DEF 14A
Source: 0001552781-25-000311
Chunk: 50

Company: CLOROX CO /DE/
Filing Date: 2025-10-07
Form: DEF 14A
Chunk 50
---
 in EP). EP is a measure we commonly evaluate and communicate as a key indication of our business performance and is substantially correlated with our stock price performance, and therefore to CAP. Unlike our multi-year PSU measure, EP is a single-year measure, meeting the SEC’s rules for the PVP table.

| The                                                                        
 Clorox Company 2025 Proxy Statement > Equity Compensation Plan Information | 78 |

Equity Compensation Plan Information The following table sets out the number of shares of common stock to be issued upon exercise of outstanding options, warrants, and rights, the weighted-average exercise price of outstanding options, warrants, and rights, and the number of securities available for future issuance under equity compensation plans as of June 30, 2025.

|                                                        |                [a] |                      [b] |                     [c] |
| Plan                                                   
 category                                               |             Number 
                 of 
   securities to be 
        issued upon 
        exercise of 
        outstanding 
 options, warrants, 
         and rights 
     (in thousands) |         Weighted-average 
           exercise price 
 per share of outstanding 
                 options, 
                warrants, 
               and rights |    Number of securities 
    remaining for future 
          issuance under 
    non-qualified stock- 
      based compensation 
     programs (excluding 
 securities reflected in 
             column [a]) 
          (in thousands) |
| Equity compensation plans approved by security holders |              4,635 |                    $ 154 |                   4,264 |
| Equity compensation                                    
 plans not approved by security holders                 |                  — |                        — |                       — |
| Total                                                  |              4,635 |                    $ 154 |                   4,264 |

Column [a] includes the following outstanding equity-based awards (in thousands):

| • | 3,157         
 stock options |

| • | 754                    
 restricted stock units |

| • | 613 performance share units and deferred shares |

| • | 111                             
 DSUs for non-employee directors |

| The                                                           
 Clorox Company 2025 Proxy Statement > Audit Committee Matters | 79 |

Audit Committee Matters

Proposal 3: Ratification of Independent Registered Public Accounting Firm

The Audit Committee has the authority to appoint, retain, compensate, and oversee the Company’s independent registered public accounting firm, and the Company’s shareholders must ratify the Audit Committee’s selection and appointment. The Audit Committee has selected Ernst & Young LLP (EY) as the Company’s independent registered public